https://medicosphere.upnjatim.ac.id/index.php/medicosphere/issue/feedJournal of Diverse Medical Research : Medicosphere2026-02-10T01:29:37+00:00Rika Yuliwulandarifk@upnjatim.ac.idOpen Journal Systems<table class="data" width="100%" bgcolor="#ddd"> <tbody> <tr valign="top"> <td width="20%">Journal title</td> <td width="80%"><strong>Journal of Diverse Medical Research : Medicosphere</strong></td> </tr> <tr valign="top"> <td width="20%">Subject</td> <td width="80%">Medical</td> </tr> <tr valign="top"> <td width="20%">Language</td> <td width="80%">English </td> </tr> <tr valign="top"> <td width="20%">eISSN</td> <td width="80%"><a href="https://portal.issn.org/resource/ISSN/3063-9433#" target="_blank" rel="noopener">3063-9433</a></td> </tr> <tr valign="top"> <td width="20%">Frequency</td> <td width="80%">12 issues per year</td> </tr> <tr valign="top"> <td width="20%">DOI</td> <td width="80%"><strong>10.33005</strong></td> </tr> <tr valign="top"> <td width="20%">Index</td> <td width="80%">No</td> </tr> <tr valign="top"> <td width="20%">Editor-in-chief</td> <td width="80%">Prof. dr. Rika Yuliwulandari, M.Hlt.Sc., Ph.D., Sp.KKLP, Subsp. FOMC</td> </tr> <tr valign="top"> <td width="20%">Publisher</td> <td width="80%">Fakultas Kedokteran UPN Veteran Jawa Timur</td> </tr> <tr valign="top"> <td width="20%">Citation Analysis</td> <td width="80%">-</td> </tr> <tr valign="top"> <td width="20%">OAI</td> <td width="80%">-</td> </tr> </tbody> </table> <p><span style="font-weight: 400;"><strong>Journal of Diverse Medical Research : Medicosphere </strong> is an open access and peer-reviewed journal, published every month by Faculty of Medicine Universitas Pembangunan Nasional Veteran Jawa Timur. This journal is a dissemination medium for research result from various areas in medical science. The editor welcome submissions of papers describing recent research related to the scope of the journal. The editors consider articles in various categories such as original article, literature review, case reports, evidence-based case reports. </span></p> <p><span style="font-weight: 400;"><strong>Scope :</strong><br /></span></p> <p><span style="font-weight: 400;">Subjects suitable for publication include, but are not limited to the following fields of </span></p> <ul> <li>Medicine</li> <li>Health Science</li> <li>Disaster Medicine</li> <li>Biomedicine</li> <li>Medical Technology</li> <li>Public Health</li> <li>Genomic</li> <li>Medical Education</li> <li>Bioethics and Medicolegal</li> </ul> <p><strong>Journal of Diverse Medical Research</strong> All submitted manuscripts undergo rigorous peer review by at least two expert reviewers in the relevant field, ensuring scientific integrity and high-quality publications.</p>https://medicosphere.upnjatim.ac.id/index.php/medicosphere/article/view/205Cerebellar Intracerebral Hemorrhage with Intraventricular Extension: A Case Report in a 62-Year-Old Male with Uncontrolled Hypertension2025-09-23T02:55:02+00:00Hiolda Verdinan Yuniarhiolda.verdinan.yuniar-2024@fk.um-surabaya.ac.idUlil Abshorulilabshorulilabshor@gmail.com<p>Intracerebral hemorrhage (ICH) is a subtype of stroke with high morbidity and mortality, where cerebellar location with intraventricular extension (IVH) is a serious condition. Uncontrolled hypertension is a major risk factor that plays a role in the occurrence of ICH. This study is a case report of a 62-year-old man with a history of uncontrolled hypertension who presented with decreased consciousness accompanied by nausea and vomiting. CT scan examination showed left cerebellar hemorrhage measuring ±18.11 cc with extension to the entire ventricular system. The patient was managed conservatively with blood pressure control, intracranial pressure reduction, and supportive therapy. During treatment, the patient experienced improved consciousness, blood pressure stabilization, and neurological function without progressive complications. This case demonstrates that appropriate and comprehensive conservative management can provide good clinical outcomes in patients with cerebellar ICH with IVH extension. This case report emphasizes the importance of early detection, appropriate intervention, and control of risk factors, especially hypertension.</p>2025-10-31T00:00:00+00:00Copyright (c) 2025 Journal of Diverse Medical Research : Medicospherehttps://medicosphere.upnjatim.ac.id/index.php/medicosphere/article/view/275Drug Eruption and Hepatitis Induced by Antituberculosis Therapy: A Case Report2026-02-10T01:29:37+00:00Muhammad Ariq Rahmanmuhammad.ariq.rahman-2024@fk.um-surabaya.ac.idLilis Asfarohlilisbungur@gmail.com<p>Pulmonary tuberculosis remains a global health issue, with one of the challenges being the adverse side effects of anti-tuberculosis drugs that can interfere with the success of therapy. This case reports a 67-year-old man with pulmonary tuberculosis who experienced a rifampicin-induced drug eruption and pyrazinamide-induced hepatitis during first-line antituberculosis combination therapy. After temporarily discontinuing the antituberculosis regimen, the patient was given supportive therapy with corticosteroid and antihistamine for the drug eruption, and stronger neo-minophagen C injections for the hepatitis. After stabilization, the regimen was adjusted to a combination of isoniazid and ethambutol, and streptomycin was added as the third agent; however, due to an allergic reaction, streptomycin was replaced with levofloxacin. The new regimen, isoniazid-ethambutol-levofloxacin, combined with appropriate management of the adverse reactions resulted in favorable clinical outcomes, marked by the disappearance of the itchy red rash on the face and body, improvement in liver function as seen from liver enzymes and bilirubin levels, and a stable general condition. This case report emphasizes the importance of being aware of the adverse side effects of antituberculosis regimens, especially in elderly patients. Regular monitoring of liver function, early detection of drug reactions, and safe and individualized regimen adjustments are important strategies to prevent complications without compromising the success of tuberculosis treatment. This case provides important lessons regarding a cautious, evidence-based clinical approach to addressing serious side effects of antituberculosis drugs.</p>2025-10-31T00:00:00+00:00Copyright (c) 2025 Journal of Diverse Medical Research : Medicosphere